Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 2338 clinical trials
Featured trial
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

This is a multicenter, open-label, dose-escalation/dose-expansion Phase 1 clinical study to investigate the safety, tolerability, PK profile, pharmacodynamics, and preliminary clinical efficacy of INCB106385 when given as monotherapy or in combination with INCMGA00012 in participants with selected CD8 T-cell-positive advanced solid tumors including SCCHN, NSCLC, ovarian cancer, CRPC, TNBC, bladder …

bladder tumor
measurable disease
cancer
cancer of the ovary
  • 36 views
  • 11 Jul, 2022
  • 19 locations
Featured trial
Hologic: Prospective Case Collection Study for New Mammography Technologies

To evaluate the safety and efficacy of the proposed investigational device and assess its clinical utility in breast cancer screening and diagnosis to support continuing technology development

  • 0 views
  • 25 Aug, 2022
  • 1 location
Featured trial
Spectrum Neutropenia in Breast Cancer

Spectrum Neutropenia in Breast Cancer

  • 238 views
  • 08 Nov, 2020
  • 1 location
Featured trial
NON-INVASIVE CONFIRMATORY DETECTION OF BREAST CANCER (NICE-BC)

NON-INVASIVE CONFIRMATORY DETECTION OF BREAST CANCER (NICE-BC)

  • 558 views
  • 25 Mar, 2021
  • 1 location
Featured trial
SWOG S1202: A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer

SWOG S1202: A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer

  • 75 views
  • 08 Nov, 2020
  • 1 location
Featured trial
SWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast Cancer with Recurrence Score (RS) of 25 or Less

SWOG S1007: A Phase III, Randomized Clinical Trial of Standard Adjuvant Endocrine Therapy +/- Chemotherapy in Patients with 1-3 Positive Nodes, Hormone Receptor-Positive and HER-2 Negative Breast

  • 148 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Breast Cancer Toxicity (CANTO)

The aims of the cohort will be to quantify impact of cancer treatments toxicities , and to generate predictors of chronic toxicity in patients with non-metastatic breast cancer. The

Accepts healthy volunteers
  • 10 views
  • 19 Apr, 2022
  • 1 location
Neoadjuvant Chemotherapy in Breast Cancer

This study compares two approaches of upfront chemotherapy in breast cancer.

  • 0 views
  • 28 Mar, 2021
  • 1 location